Surabhi Mulchandani
Overview
Explore the profile of Surabhi Mulchandani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Merrill A, Hackenmueller S, Derdeyn C, Genzen J, Gruson D, Ludgate M, et al.
Clin Chem
. 2024 Jun;
70(8):1009-1016.
PMID: 38873889
No abstract available.
2.
Master S, Neide B, Kollu S, Mulchandani S, Harris R, Obstfeld A
Acad Pathol
. 2021 Apr;
8:23742895211006822.
PMID: 33884294
The Coronavirus 2019 pandemic has strained nearly every aspect of pathology practice, including preanalytic, analytic, and postanalytic processes. Much of the challenges result from high demand for limited severe acute...
3.
Balciuniene J, Dechene E, Akgumus G, Romasko E, Cao K, Dubbs H, et al.
JAMA Netw Open
. 2019 Apr;
2(4):e192129.
PMID: 30977854
Importance: Although genetic testing is important for bringing precision medicine to children with epilepsy, it is unclear what genetic testing strategy is best in maximizing diagnostic yield. Objectives: To evaluate...
4.
Luo M, Fan J, Wenger T, Harr M, Racobaldo M, Mulchandani S, et al.
Am J Med Genet A
. 2017 May;
173(8):2101-2107.
PMID: 28504353
Autism spectrum disorder (ASD) is a genetically heterogeneous group of disorders characterized by impairments in social communication and restricted interests. Though some patients with ASD have an identifiable genetic cause,...
5.
Reiff M, Bugos E, Giarelli E, Bernhardt B, Spinner N, Sankar P, et al.
J Autism Dev Disord
. 2017 Feb;
47(5):1453-1463.
PMID: 28229350
Despite increasing utilization of chromosomal microarray analysis (CMA) for autism spectrum disorders (ASD), limited information exists about how results influence parents' beliefs about etiology and prognosis. We conducted in-depth interviews...
6.
Mulchandani S, Bhoj E, Luo M, Powell-Hamilton N, Jenny K, Gripp K, et al.
Genet Med
. 2015 Aug;
18(4):309-15.
PMID: 26248010
Purpose: Maternal uniparental disomy of chromosome 20 (UPD(20)mat) has been reported in only four patients, three of whom also had mosaicism for complete or partial trisomy of chromosome 20. We...
7.
Luo M, Mulchandani S, Dubbs H, Swarr D, Pyle L, Zackai E, et al.
Am J Med Genet A
. 2015 Jul;
167A(12):3091-5.
PMID: 26198585
Discordance between clinical phenotype and genotype has multiple causes, including mosaicism. Phenotypes can be modified due to tissue distribution, or the presence of multiple abnormal cell lines with different genomic...
8.
Reiff M, Giarelli E, Bernhardt B, Easley E, Spinner N, Sankar P, et al.
J Autism Dev Disord
. 2015 Jun;
45(10):3262-75.
PMID: 26066358
Clinical guidelines recommend chromosomal microarray analysis (CMA) for all children with autism spectrum disorders (ASDs). We explored the test's perceived usefulness among parents of children with ASD who had undergone...
9.
Amendola L, Dorschner M, Robertson P, Salama J, Hart R, Shirts B, et al.
Genome Res
. 2015 Feb;
25(3):305-15.
PMID: 25637381
Recommendations for laboratories to report incidental findings from genomic tests have stimulated interest in such results. In order to investigate the criteria and processes for assigning the pathogenicity of specific...
10.
Reiff M, Mueller R, Mulchandani S, Spinner N, Pyeritz R, Bernhardt B
J Genet Couns
. 2013 Sep;
23(4):474-88.
PMID: 24037030
The utilization of genome-wide chromosomal microarray analysis (CMA) in pediatric clinical practice provides an opportunity to consider how genetic diagnostics is evolving, and to prepare for the clinical integration of...